291 related articles for article (PubMed ID: 36354702)
1. CD36 and Its Role in Regulating the Tumor Microenvironment.
Liao X; Yan S; Li J; Jiang C; Huang S; Liu S; Zou X; Zhang G; Zou J; Liu Q
Curr Oncol; 2022 Oct; 29(11):8133-8145. PubMed ID: 36354702
[TBL] [Abstract][Full Text] [Related]
2. CD36 promotes vasculogenic mimicry in melanoma by mediating adhesion to the extracellular matrix.
Martini C; DeNichilo M; King DP; Cockshell MP; Ebert B; Dale B; Ebert LM; Woods A; Bonder CS
BMC Cancer; 2021 Jul; 21(1):765. PubMed ID: 34215227
[TBL] [Abstract][Full Text] [Related]
3. CD36-TSP-HRGP interactions in the regulation of angiogenesis.
Silverstein RL; Febbraio M
Curr Pharm Des; 2007; 13(35):3559-67. PubMed ID: 18220792
[TBL] [Abstract][Full Text] [Related]
4. Fatty Acids, CD36, Thrombospondin-1, and CD47 in Glioblastoma: Together and/or Separately?
Tanase C; Enciu AM; Codrici E; Popescu ID; Dudau M; Dobri AM; Pop S; Mihai S; Gheorghișan-Gălățeanu AA; Hinescu ME
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054787
[TBL] [Abstract][Full Text] [Related]
5. CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo.
Koch M; Hussein F; Woeste A; Gründker C; Frontzek K; Emons G; Hawighorst T
Breast Cancer Res Treat; 2011 Jul; 128(2):337-46. PubMed ID: 20714802
[TBL] [Abstract][Full Text] [Related]
6. Context dependent role of the CD36--thrombospondin--histidine-rich glycoprotein axis in tumor angiogenesis and growth.
Hale JS; Li M; Sinyuk M; Jahnen-Dechent W; Lathia JD; Silverstein RL
PLoS One; 2012; 7(7):e40033. PubMed ID: 22808089
[TBL] [Abstract][Full Text] [Related]
7. CD36 tango in cancer: signaling pathways and functions.
Wang J; Li Y
Theranostics; 2019; 9(17):4893-4908. PubMed ID: 31410189
[TBL] [Abstract][Full Text] [Related]
8. CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells.
Dawson DW; Pearce SF; Zhong R; Silverstein RL; Frazier WA; Bouck NP
J Cell Biol; 1997 Aug; 138(3):707-17. PubMed ID: 9245797
[TBL] [Abstract][Full Text] [Related]
9. CD36: a critical anti-angiogenic receptor.
Simantov R; Silverstein RL
Front Biosci; 2003 Sep; 8():s874-82. PubMed ID: 12957861
[TBL] [Abstract][Full Text] [Related]
10. Expression and localization of thrombospondin-1 and -2 and their cell-surface receptor, CD36, during rat follicular development and formation of the corpus luteum.
Petrik JJ; Gentry PA; Feige JJ; LaMarre J
Biol Reprod; 2002 Nov; 67(5):1522-31. PubMed ID: 12390884
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of tumor growth by systemic treatment with thrombospondin-1 peptide mimetics.
Reiher FK; Volpert OV; Jimenez B; Crawford SE; Dinney CP; Henkin J; Haviv F; Bouck NP; Campbell SC
Int J Cancer; 2002 Apr; 98(5):682-9. PubMed ID: 11920636
[TBL] [Abstract][Full Text] [Related]
12. Capillary sprout endothelial cells exhibit a CD36 low phenotype: regulation by shear stress and vascular endothelial growth factor-induced mechanism for attenuating anti-proliferative thrombospondin-1 signaling.
Anderson CR; Hastings NE; Blackman BR; Price RJ
Am J Pathol; 2008 Oct; 173(4):1220-8. PubMed ID: 18772338
[TBL] [Abstract][Full Text] [Related]
13. Expression of thrombospondin-1 in cancer: a role in tumor progression.
Qian X; Tuszynski GP
Proc Soc Exp Biol Med; 1996 Jul; 212(3):199-207. PubMed ID: 8677265
[TBL] [Abstract][Full Text] [Related]
14. Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes.
Cursiefen C; Maruyama K; Bock F; Saban D; Sadrai Z; Lawler J; Dana R; Masli S
J Exp Med; 2011 May; 208(5):1083-92. PubMed ID: 21536744
[TBL] [Abstract][Full Text] [Related]
15. Thrombospondin in Tumor Microenvironment.
Ramchandani D; Mittal V
Adv Exp Med Biol; 2020; 1272():133-147. PubMed ID: 32845506
[TBL] [Abstract][Full Text] [Related]
16. Ligand-dependent CD36 functions in cancer progression, metastasis, immune response, and drug resistance.
Xia L; Zhou Z; Chen X; Luo W; Ding L; Xie H; Zhuang W; Ni K; Li G
Biomed Pharmacother; 2023 Dec; 168():115834. PubMed ID: 37931517
[TBL] [Abstract][Full Text] [Related]
17. Priming of the vascular endothelial growth factor signaling pathway by thrombospondin-1, CD36, and spleen tyrosine kinase.
Kazerounian S; Duquette M; Reyes MA; Lawler JT; Song K; Perruzzi C; Primo L; Khosravi-Far R; Bussolino F; Rabinovitz I; Lawler J
Blood; 2011 Apr; 117(17):4658-66. PubMed ID: 21378271
[TBL] [Abstract][Full Text] [Related]
18. Thrombospondin-4 in tissue remodeling.
Stenina-Adognravi O; Plow EF
Matrix Biol; 2019 Jan; 75-76():300-313. PubMed ID: 29138119
[TBL] [Abstract][Full Text] [Related]
19. Thrombospondin 4/integrin α2/HSF1 axis promotes proliferation and cancer stem-like traits of gallbladder cancer by enhancing reciprocal crosstalk between cancer-associated fibroblasts and tumor cells.
Shi Y; Sun L; Zhang R; Hu Y; Wu Y; Dong X; Dong D; Chen C; Geng Z; Li E; Fan Y
J Exp Clin Cancer Res; 2021 Jan; 40(1):14. PubMed ID: 33407730
[TBL] [Abstract][Full Text] [Related]
20. CD36: The Bridge between Lipids and Tumors.
Zhou X; Su M; Lu J; Li D; Niu X; Wang Y
Molecules; 2024 Jan; 29(2):. PubMed ID: 38276607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
